It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Vascular endothelial cells (ECs) form a dynamic interface between blood and tissue and play a crucial role in the progression of vascular inflammation. Here, we aim to dissect the system-wide molecular mechanisms of inflammatory endothelial-cytokine responses. Applying an unbiased cytokine library, we determined that TNFα and IFNγ induced the largest EC response resulting in distinct proteomic inflammatory signatures. Notably, combined TNFα + IFNγ stimulation induced an additional synergetic inflammatory signature. We employed a multi-omics approach to dissect these inflammatory states, combining (phospho-) proteome, transcriptome and secretome and found, depending on the stimulus, a wide-array of altered immune-modulating processes, including complement proteins, MHC complexes and distinct secretory cytokines. Synergy resulted in cooperative activation of transcript induction. This resource describes the intricate molecular mechanisms that are at the basis of endothelial inflammation and supports the adaptive immunomodulatory role of the endothelium in host defense and vascular inflammation.
Combined TNFα + IFNγ stimulation induces a synergetic inflammatory signature, which is the basis of endothelial inflammation, emphasizing the role of endothelial cell-cytokine interactions in inflammatory pathogenesis and role of endothelial cells in inflammation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Sanquin Research, Department of Molecular Hematology, Amsterdam, The Netherlands (GRID:grid.417732.4) (ISNI:0000 0001 2234 6887)
2 Sanquin Research, Department of Molecular Hematology, Amsterdam, The Netherlands (GRID:grid.417732.4) (ISNI:0000 0001 2234 6887); Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Department of Biomolecular Mass Spectrometry and Proteomics, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234)